Shares of Amgen Inc. AMGN slipped 1.37% to $272.05 Thursday, on what proved to be an all-around positive trading session for ...

The jury after just over half a day of deliberations found Amgen Inc. liable on 10 of the 11 claims in the complaint, including monopolization and unreasonable restraint of trade in violation of the ...

In this article, we are going to take a look at where Amgen Inc. (NASDAQ:AMGN) stands against other Dow stocks. The Dow Jones Industrial Average is a benchmark index of the top 30 companies in the US.

We recently published a list of Domestic Manufacturing Boom: 12 Best Pharma Stocks to Invest in Now. In this article, we are ...

A federal jury in Delaware said on Thursday that biotech company Amgen owes competitor Regeneron more than $406 million for ...

THOUSAND OAKS, Calif. (AP) — THOUSAND OAKS, Calif. (AP) — Amgen Inc. (AMGN) on Thursday reported first-quarter net income of $1.73 billion, after reporting a loss in the same period a year ...

Global Product Sales Growth: 14% in the US. Amgen Inc (NASDAQ:AMGN) reported a 9% year-over-year revenue growth, with a 14% increase in volume, driven by strong demand for its innovative medicines.

In the long-running feud between Regeneron and Amgen around the companies’ competing PCSK9 cholesterol meds, Regeneron has eked out another legal win over its rival. | A federal jury in Delaware has ...

Regeneron (REGN) wins $400M in damages as jury finds Amgen (AMGN) violated antitrust laws by promoting its heart drug Repatha ...

Q1 2025 Earnings Call Transcript May 1, 2025 Amgen Inc. beats earnings expectations. Reported EPS is $4.9, expectations were $4.27. Operator: My name is Julianne and I’ll be your conference ...

Looking at the universe of stocks we cover at Dividend Channel, on 5/16/25, Amgen Inc (Symbol: AMGN), Banco Latinoamericano de Comercio Exterior, S.A. (Symbol: BLX), and Sabra Health Care REIT Inc ...